Media Summary: In this video, Adrian Mosquera Orgueira, MD, PhD, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), ... Shankara Anand, MD, MS, Boston University School of Medicine, Boston, MA, discusses research exploring the use of An overview regarding the evolution of prognostic scoring systems used to stratify patients who present with primary

Machine Learning Improves Risk Stratification In Myelofibrosis - Detailed Analysis & Overview

In this video, Adrian Mosquera Orgueira, MD, PhD, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), ... Shankara Anand, MD, MS, Boston University School of Medicine, Boston, MA, discusses research exploring the use of An overview regarding the evolution of prognostic scoring systems used to stratify patients who present with primary Join Drs Tania Jain and Pankit Vachhani as they discuss the nuance involved in the Adrián Mosquera Orgueira, MD, PhD, is a hematologist at the University Hospital of Santiago de Compostela, Spain, and group ... Expert panelists Harry P. Erba, MD, PhD; Jamile M. Shammo, MD, FASCP, FACP; Ruben A. Mesa, MD, FACP; Srdan Verstovsek, ...

David Marks, MBBS, PhD, FRACP, FRCPath, University Hospitals Bristol NHS Trust, Bristol, UK, explains how

Photo Gallery

Machine Learning Improves Risk Stratification in Myelofibrosis
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Regist...
Enhancing myelofibrosis prognostication with machine learning
Machine learning-based clustering to improve risk stratification in newly diagnosed AL amyloidosis
4. Risk Stratification, Part 1
Primary Myelofibrosis: Risk Stratification
Optimized risk stratification and treatment decisions with machine learning
Machine Learning Program Improves Transplant Risk Prediction for Myelofibrosis Patients
S1 Episode 1: Risk Stratification in Myelofibrosis: Which Model Should You Use?
Risk Stratification in Myelofibrosis
How Is Machine Learning Augmenting Decision Making in Myelofibrosis Care?
Myelofibrosis: Diagnosis and Risk Stratification
Sponsored
View Detailed Profile
Machine Learning Improves Risk Stratification in Myelofibrosis

Machine Learning Improves Risk Stratification in Myelofibrosis

Machine Learning

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Regist...

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Regist...

Machine Learning

Enhancing myelofibrosis prognostication with machine learning

Enhancing myelofibrosis prognostication with machine learning

In this video, Adrian Mosquera Orgueira, MD, PhD, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), ...

Machine learning-based clustering to improve risk stratification in newly diagnosed AL amyloidosis

Machine learning-based clustering to improve risk stratification in newly diagnosed AL amyloidosis

Shankara Anand, MD, MS, Boston University School of Medicine, Boston, MA, discusses research exploring the use of

4. Risk Stratification, Part 1

4. Risk Stratification, Part 1

MIT 6.S897

Sponsored
Primary Myelofibrosis: Risk Stratification

Primary Myelofibrosis: Risk Stratification

An overview regarding the evolution of prognostic scoring systems used to stratify patients who present with primary

Optimized risk stratification and treatment decisions with machine learning

Optimized risk stratification and treatment decisions with machine learning

... role that

Machine Learning Program Improves Transplant Risk Prediction for Myelofibrosis Patients

Machine Learning Program Improves Transplant Risk Prediction for Myelofibrosis Patients

A new

S1 Episode 1: Risk Stratification in Myelofibrosis: Which Model Should You Use?

S1 Episode 1: Risk Stratification in Myelofibrosis: Which Model Should You Use?

Join Drs Tania Jain and Pankit Vachhani as they discuss the nuance involved in the

Risk Stratification in Myelofibrosis

Risk Stratification in Myelofibrosis

Discussion of

How Is Machine Learning Augmenting Decision Making in Myelofibrosis Care?

How Is Machine Learning Augmenting Decision Making in Myelofibrosis Care?

Adrián Mosquera Orgueira, MD, PhD, is a hematologist at the University Hospital of Santiago de Compostela, Spain, and group ...

Myelofibrosis: Diagnosis and Risk Stratification

Myelofibrosis: Diagnosis and Risk Stratification

Expert panelists Harry P. Erba, MD, PhD; Jamile M. Shammo, MD, FASCP, FACP; Ruben A. Mesa, MD, FACP; Srdan Verstovsek, ...

Improving risk stratification in ALL with risk scores & genomic studies to personalize therapy

Improving risk stratification in ALL with risk scores & genomic studies to personalize therapy

David Marks, MBBS, PhD, FRACP, FRCPath, University Hospitals Bristol NHS Trust, Bristol, UK, explains how